Literature DB >> 28824832

Preliminary Monte Carlo Investigation of Using Ir-192 as the Source for Real Time Imaging Purpose.

Chengyu Shi1, Brian Wang2.   

Abstract

The purpose of this study is to investigate the potential use of Ir-192 as the source for real time imaging during HDR (High Dose Rate) brachytherapy treatment. Phantom measurement was performed to determine outside of the body dose. Monte Carlo code, EGSnrcMP egs_inprz, was used for the simulation to calculate the outside of the body x-ray signal for CT reconstruction. Matlab code was developed to reconstruct the Ir-192 source and for 3D visualization in order to assess reconstructed CT resolution, signal-to-noise ratio, and imaging dose information. The measured dose was 0.67 ± 0.04 cGy, which was comparable to the Monte Carlo simulation result 0.71 ± 0.20 cGy. The reconstructed source diameter dimension was 1.3 mm compared with 1.1 mm for the real source dimension. The signal-to-noise ratio was 19.91 db following de-noising. Source position was within a 1 mm difference between programmed and simulated results. Although the Ir-192 signal is weak for CT imaging, it is possible to use it as a CT imaging x-ray source for HDR treatment localization, verification and dosimetry purposes. Further study is needed for the detailed design of an outside of the body CT-like device for use in brachytherapy imaging.

Entities:  

Keywords:  HDR; Imaging; Ir-192; Monte Carlo

Year:  2017        PMID: 28824832      PMCID: PMC5562365          DOI: 10.4236/ijmpcero.2017.61003

Source DB:  PubMed          Journal:  Int J Med Phys Clin Eng Radiat Oncol        ISSN: 2168-5436


  16 in total

1.  Possibilities for intensity-modulated brachytherapy: technical limitations on the use of non-isotropic sources.

Authors:  M A Ebert
Journal:  Phys Med Biol       Date:  2002-07-21       Impact factor: 3.609

2.  BrachyView, a novel in-body imaging system for HDR prostate brachytherapy: Experimental evaluation.

Authors:  M Safavi-Naeini; Z Han; S Alnaghy; D Cutajar; M Petasecca; M L F Lerch; D R Franklin; J Bucci; M Carrara; M Zaider; A B Rosenfeld
Journal:  Med Phys       Date:  2015-12       Impact factor: 4.071

3.  BrachyView: proof-of-principle of a novel in-body gamma camera for low dose-rate prostate brachytherapy.

Authors:  M Petasecca; K J Loo; M Safavi-Naeini; Z Han; P E Metcalfe; S Meikle; S Pospisil; J Jakubek; J A Bucci; M Zaider; M L F Lerch; Y Qi; A B Rosenfeld
Journal:  Med Phys       Date:  2013-04       Impact factor: 4.071

4.  Interstitial rotating shield brachytherapy for prostate cancer.

Authors:  Quentin E Adams; Jinghzu Xu; Elizabeth K Breitbach; Xing Li; Shirin A Enger; William R Rockey; Yusung Kim; Xiaodong Wu; Ryan T Flynn
Journal:  Med Phys       Date:  2014-05       Impact factor: 4.071

Review 5.  A review of safety, quality management, and practice guidelines for high-dose-rate brachytherapy: executive summary.

Authors:  Bruce R Thomadsen; Beth A Erickson; Patricia J Eifel; I-Chow Hsu; Rakesh R Patel; Daniel G Petereit; Benedick A Fraass; Mark J Rivard
Journal:  Pract Radiat Oncol       Date:  2014-02-05

6.  A real-time applicator position monitoring system for gynecologic intracavitary brachytherapy.

Authors:  Junyi Xia; Timothy Waldron; Yusung Kim
Journal:  Med Phys       Date:  2014-01       Impact factor: 4.071

7.  Asymmetric dose-volume optimization with smoothness control for rotating-shield brachytherapy.

Authors:  Yunlong Liu; Ryan T Flynn; Yusung Kim; Xiaodong Wu
Journal:  Med Phys       Date:  2014-11       Impact factor: 4.071

8.  Dynamic rotating-shield brachytherapy.

Authors:  Yunlong Liu; Ryan T Flynn; Yusung Kim; Wenjun Yang; Xiaodong Wu
Journal:  Med Phys       Date:  2013-12       Impact factor: 4.071

9.  Multihelix rotating shield brachytherapy for cervical cancer.

Authors:  Hossein Dadkhah; Yusung Kim; Xiaodong Wu; Ryan T Flynn
Journal:  Med Phys       Date:  2015-11       Impact factor: 4.071

10.  Rapid emission angle selection for rotating-shield brachytherapy.

Authors:  Yunlong Liu; Ryan T Flynn; Wenjun Yang; Yusung Kim; Sudershan K Bhatia; Wenqing Sun; Xiaodong Wu
Journal:  Med Phys       Date:  2013-05       Impact factor: 4.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.